Predictors of postpartum viral load rebound in a cohort of HIV-infected Brazilian women

International Journal of Gynecology and Obstetrics

Volumn 108, Issue 2, 2010, Pages 111-114

  Cavallo, Ines Katerina ^a   Kakehasi, Fabiana Maria ^a   Andrade, Beatriz Amélia ^a   Lobato, Ana Cristina ^a   Aguiar, Regina Amélia ^a   Pinto, Jorge Andrade ^a   Melo, Victor Hugo ^a  

^a School of Medicine   (Brazil)

Author keywords

CD4 lymphocytes; HIV; Postpartum; Potent antiretrovirals; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAZIL; CD4 LYMPHOCYTE COUNT; DRUG WITHDRAWAL; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PREGNANCY; PRENATAL CARE; PRIORITY JOURNAL; PROPHYLAXIS; PUERPERIUM; VERTICAL TRANSMISSION; VIRUS LOAD;

EID: 73749088461     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2009.09.014     Document Type: Article

References (18)

1. Hocke C., Morlat P., Chene G., Dequae L., and Dabis F. Prospective cohort study of the effect of pregnancy on the progression of human immunodeficiency virus infection. Obstet Gynecol 86 6 (1995) 886-891
2. Tai J.H., Udoji M.A., Barkanic G., Byrne D.W., Rebeiro P.F., Byram B.R., et al. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy. J Infect Dis 196 7 (2007) 1044-1052
3. Read J.S., Cahn P., Losso M., Pinto J., Joao E., Duarte G., et al. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites. Obstet Gynecol 109 6 (2007) 1358-1367
4. Cao Y., Krogstad P., Korber B.T., Koup R.A., Muldoon M., Macken C., et al. Maternal HIV-1 viral load and vertical transmission of infection: the Ariel Project for the prevention of HIV transmission from mother to infant. Nat Med 3 5 (1997) 549-552
5. Melvin A.J., Burchett S.K., Watts D.H., Hitti J., Hughes J.P., McLellan C.L., et al. Effect of pregnancy and zidovudine therapy on viral load in HIV-1-infected women. J Acquir Immune Defic Syndr Hum Retrovirol 14 3 (1997) 232-236
6. Watts D.H., Lambert J., Stiehm E.R., Harris D.R., Bethel J., Mofenson L., et al. Progression of HIV disease among women following delivery. J Acquir Immune Defic Syndr 33 5 (2003) 585-593
7. Tungsiripat M., Drechsler H., and Aberg J.A. Discontinuation of ART postpartum: no evidence for altered viral set point [letter]. JAIDS 44 1 (2007) 116-117
8. El-Sadr W.M., Lundgren J.D., Neaton J.D., Gordin F., Abrams D., Arduino R.C., et al. CD4+ count-guided interruption of antiretroviral treatment. N Engl J Med 355 22 (2006) 2283-2296
9. Pai N.P., Lawrence J., Reingold A.L., and Tulsky J.P. Structured treatment interruptions (STI) in chronic unsuppressed HIV infection in adults. Cochrane Database Syst Rev 3 (2006) CD006148
10. Kakehasi F.M., Tupinambás U., Cleto S., Aleixo A., Lin E., Melo V.H., et al. Persistence of genotypic resistance to nelfinavir among women exposed to prophylactic antiretroviral therapy during pregnancy. AIDS Res Hum Retrovir 23 12 (2007) 1515-1520
11. Centers for Disease Control and Prevention (US). 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41 RR-17 (1992) 1-19
12. Mocroft A., Ruiz L., Reiss P., Ledergerber B., Katlama C., Lazzarin A., et al. Virological rebound after suppression on highly active antiretroviral therapy. AIDS 17 12 (2003) 1741-1751
13. Bansi L.K., Benzie A.A., Phillips A.N., Portsmouth S., Hill T., Leen C., et al. Are previous treatment interruptions associated with higher viral rebound rates in patients with viral suppression?. AIDS 22 3 (2008) 349-356
14. Danel C., Moh R., Minga A., Anzian A., Ba-Gomis O., Kanga C., et al. CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in West Africa (Trivacan ANRS 1269 Trial): a randomized trial. Lancet 367 (2006) 1981-1989
15. Garcia F., Plana M., Ortiz G.M., Bonhoeffer S., Soriano A., Vidal C., et al. The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection. AIDS 15 9 (2001) F29-F40
16. Bahrani A., Ramaswamy R., and Oldfield III E.C. Effects of Virologic Rebound on CD4 cell counts. Clin Infect Dis 32 (2001) 1231-1232
17. Ledergeber B., Egger M., Opravil M., Telenti A., Hirschel B., Battegay M., et al. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Lancet 353 9156 (1999) 863-868
18. Cunningham C.K., Chaix M.L., Rekacewicz C., Britto P., Rouzioux C., Gelber R.D., et al. Development of resistance mutations in women receiving standard antiretroviral therapy who received intrapartum nevirapine to prevent perinatal human immunodeficiency virus type 1 transmission: a substudy of Pediatrics AIDS Clinical Trials Group protocol 316. J Infect Dis 186 2 (2002) 181-188